(Q33804499)

29 July 2017

1 reference

title

The clinical pharmacokinetics of the new antiepileptic drugs (English)

1 reference

29 July 2017

1 reference

E Perucca

1

1 reference

29 July 2017

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

40 Suppl 9

1 reference

29 July 2017

S7-13

1 reference

The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid

29 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

Effect of a high-protein meal on gabapentin pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

A single-dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

Interactions involving new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

Pharmacokinetic interaction studies between felbamate and vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

Evaluation of case reports of aplastic anemia among patients treated with felbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

Disabling tremor after lamotrigine with sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

Interaction between vigabatrin and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB02088.X

10.1111/J.1528-1157.1999.TB02088.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10612356